Market Closed -
Other stock markets
|
After market 03:07:43 pm | |||
1.96 EUR | +1.24% | 1.957 | -0.15% |
Apr. 04 | AB Science's Reconsideration Request for ALS Treatment Granted Eligibility in Canada | MT |
Apr. 03 | AB Science: reconsideration possible for masitinib in ALS | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-44.87% | 106M | |
+4.06% | 70.44B | |
+10.97% | 8.94B | |
-14.44% | 4.75B | |
+41.60% | 4.5B | |
+5.96% | 3.85B | |
+23.46% | 2.38B | |
-19.32% | 2.34B | |
-27.04% | 2.2B | |
+7.97% | 1.96B |
- Stock Market
- Equities
- AB Stock
- News AB Science
- AB Science's Reconsideration Request for ALS Treatment Granted Eligibility in Canada